Patcharawalai Whongsiri

Dr. Patcharawalai Whongsiri

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
PWPatcharawalai Whongsiri
Patcharawalai Whongsiri
WGWolfgang Goering
Wolfgang Goering
TLTobias Lautwein
Tobias Lautwein
CHChristiane Hader
Christiane Hader
GNGünter Niegisch
Günter Niegisch
WSWolfgang Schulz
Wolfgang Schulz
Human genomes contain about 100,000 LINE-1 (L1) retroelements, of which more than 100 are intact. L1s are normally tightly controlled by epigenetic mechanisms, which often fail in cancer. In bladder urothelial carcinoma (UC), particularly, L1s become DNA-hypomethylated, expressed and contribute to genomic instability and tumor growth. It is, however, unknown which individual L1s are activated. Following RNA-immunoprecipitation with a L1-specific antibody, third generation nanopore sequencing detected transcripts of 90 individual elements in the VM-Cub-1 UC line with high overall L1 expression. In total, 10 L1s accounted for >60% of the reads. Analysis of five specific L1s by RT-qPCR revealed generally increased expression in UC tissues and cell lines over normal controls, but variable expression among tumor cell lines from bladder, prostate and testicular cancer. Chromatin immunoprecipitation demonstrated active histone marks at L1 sequences with increased expression in VM-Cub-1, but not in a different UC cell line with low L1 expression. We conclude that many L1 elements are epigenetically activated in bladder cancer in a varied pattern. Our findings indicate that expression of individual L1s is highly heterogeneous between and among cancer types.

21 April 2020 in Cancers
Verified
Journal Article
Open access
PDF file
ALAlexander Lang
Alexander Lang
PWPatcharawalai Whongsiri
Patcharawalai Whongsiri
MYMerve Yilmaz
Merve Yilmaz
TLTobias Lautwein
Tobias Lautwein
PPPatrick Petzsch
Patrick Petzsch
WSWolfgang Schulz
Wolfgang Schulz
The histone demethylase UTX (gene: KDM6A) directs cell and tissue differentiation during development. Deleterious mutations in KDM6A occur in many human cancers, most frequently in urothelial carcinoma. The consequences of these mutations are poorly understood; plausibly, they may disturb urothelial differentiation. We therefore investigated the effects of UTX siRNA-mediated knockdown in two in vitro models of urothelial differentiation; namely, primary cultures of urothelial epithelial cells treated with troglitazone and PD153035 and the immortalized urothelial cell line HBLAK treated with high calcium and serum. In both models, efficient UTX knockdown did not block morphological and biochemical differentiation. An apparent delay was due to a cytotoxic effect on the cell cultures before the initiation of differentiation, which induced apoptosis partly in a p53-dependent manner. As a consequence, slowly cycling, smaller, KRT14high precursor cells in the HBLAK cell line were enriched at the expense of more differentiated, larger, proliferating KRT14low cells. UTX knockdown induced apoptosis and enriched KRT14high cells in the BFTC-905 papillary urothelial carcinoma cell line as well. Our findings suggest an explanation for the frequent occurrence of KDM6A mutations across all stages and molecular subtypes of urothelial carcinoma, whereby loss of UTX function does not primarily impede later stages of urothelial differentiation, but favors the expansion of precursor populations to provide a reservoir of potential tumor-initiating cells.

7 July 2023
Verified
Book Chapter
Closed access
PDF file
CPChristoph Peter
Christoph Peter
WSWolfgang A. Schulz
Wolfgang A. Schulz
PWPatcharawalai Whongsiri
Patcharawalai Whongsiri

2 October 2024 in Chulalongkorn Medical Journal
Verified
Journal Article
Open access
PDF file
SKSotida Kayem
Sotida Kayem
SPSuchittra Phoyen
Suchittra Phoyen
PWPatcharawalai Whongsiri
Patcharawalai Whongsiri
CPChaowat Pimratana
Chaowat Pimratana
UWUdomsak Wijitsettakul
Udomsak Wijitsettakul
CBChanchai Boonla
Chanchai Boonla
Background: Previously, we demonstrated that reactive oxygen species (ROS) provoked oxidative stress, enhanced tumor aggressiveness, and induced a profound change in histone methylation in bladder cancer (BlCa). We also reported an upregulation of H4K20me3 by ROS in hepatocellular carcinoma. In this study, we investigated whether H4K20me3 was upregulated in human BlCa tissues (n = 37) and asked if ROS could induce H4K20me3 formation in BlCa cell lines. Methods: Immunohistochemical (IHC) staining was performed in 37 BlCa sections and 6 adjacent noncancerous tissues (as controls). H4K20me3 upregulated by ROS was investigated in three BlCa cell lines (UM-UC-3, VM- CUB-1 and TCCSUP). Results: H4K20me3 level in BlCa tissues was increased relative to the adjacent noncancerous tissues. The IHC score of H4K20me3 level in BlCa tissues was significantly higher than in noncancerous controls. H 2 O 2 (ROS representative) at 50, 100 and 200 M significantly provoked oxidative stress in UM-UC-3, VM-CUB-1 and TCCSUP cells, respectively, but not significantly alter cell survival. The results from both western blot and immunofluorescent staining showed that treatment with H 2 O 2 markedly increased H4K20me3 formation in all three cell lines. Conclusion: We demonstrated H4K20me3 level in BlCa tissues obtained from Thai BlCa patients was increased compared with the adjacent noncancerous tissues. Evidently, ROS upregulated H4K20me3 formation in BlCa cell lines. Whether ROS-induced BlCa progression is mediated through H4K20me3 formation remains to be elucidated.